NYSTOP Drug Patent Profile
✉ Email this page to a colleague
When do Nystop patents expire, and what generic alternatives are available?
Nystop is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in NYSTOP is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nystop
A generic version of NYSTOP was approved as nystatin by FOUGERA PHARMS on September 23rd, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NYSTOP?
- What are the global sales for NYSTOP?
- What is Average Wholesale Price for NYSTOP?
Summary for NYSTOP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Drug Prices: | Drug price information for NYSTOP |
| Drug Sales Revenues: | Drug sales revenues for NYSTOP |
| DailyMed Link: | NYSTOP at DailyMed |
Pharmacology for NYSTOP
| Drug Class | Polyene Antifungal |
US Patents and Regulatory Information for NYSTOP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | NYSTOP | nystatin | POWDER;TOPICAL | 064118-001 | Aug 16, 1996 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
